Table 2.
Posttreatment relapse incidence of genital condylomatosis stratified for age, gender, and grade.
|
Group A N = 64
N (%) |
Group B N = 61
N(%) |
P value1 | ||
|---|---|---|---|---|
| 1-month follow-up | ||||
|
| ||||
| Total group | Negative | 54 (84.4) | 36 (59.0) | <.01 |
|
| ||||
| Positive | 10 (15.6) | 25 (41.0) | ||
|
| ||||
| Age (years) | ||||
|
| ||||
| ≤ 25 | Negative | 6 (66.7) | 3 (42.9) | NS |
|
| ||||
| Positive | 3 (33.3) | 4 (57.1) | ||
|
| ||||
| > 25 | Negative | 48 (87.3) | 33 (61.1) | <.01 |
|
| ||||
| Positive | 7 (12.7) | 21 (38.9) | ||
|
| ||||
| Gender | ||||
|
| ||||
| Females | Negative | 42 (87.5) | 29 (69.0) | <.05 |
|
| ||||
| Positive | 6 (12.5) | 13 (31.0) | ||
|
| ||||
| Males | Negative | 12 (75.0) | 7 (36.8) | <.05 |
|
| ||||
| Positive | 4 (25.0) | 12 (63.2) | ||
|
| ||||
| Grade 2 | ||||
|
| ||||
| 1 | Negative | 34 (91.9) | 25 (75.8) | NS |
|
| ||||
| Positive | 3 (8.1) | 8 (24.2) | ||
|
| ||||
| 2 | Negative | 17 (77.3) | 11 (50.0) | NS |
|
| ||||
| Positive | 5 (22.7) | 11 (50.0) | ||
|
| ||||
| 3 | Negative | 3 (60.0) | 0 (0) | <.05 |
|
| ||||
| Positive | 2 (40.0) | 6 (100) | ||
|
| ||||
| 6-month follow-up | ||||
|
| ||||
| Total | Negative | 56 (87.5) | 37 (60.7) | <.001 |
|
| ||||
| Positive | 8 (12.5) | 24 (39.3) | ||
|
| ||||
| Age (years) | ||||
|
| ||||
| ≤ 25 | Negative | 7 (77.8) | 4 (57.1) | NS |
|
| ||||
| Positive | 2 (22.2) | 3 (42.9) | ||
|
| ||||
| > 25 | Negative | 49 (89.1) | 33 (61.1) | <.001 |
|
| ||||
| Positive | 6 (10.9) | 21 (38.9) | ||
|
| ||||
| Gender | ||||
|
| ||||
| Females | Negative | 43 (89.6) | 30 (71.4) | <.05 |
|
| ||||
| Positive | 5 (10.4) | 12 (28.6) | ||
|
| ||||
| Males | Negative | 13 (81.2) | 7 (36.8) | <.05 |
|
| ||||
| Positive | 3 (18.8) | 12 (63.2) | ||
|
| ||||
| Grade 2 | ||||
|
| ||||
| 1 | Negative | 35 (94.6) | 25 (75.8) | <.05 |
|
| ||||
| Positive | 2 (5.4) | 8 (24.2) | ||
|
| ||||
| 2 | Negative | 17 (77.3) | 11 (50.0) | NS |
|
| ||||
| Positive | 5 (22.7) | 11 (50.0) | ||
|
| ||||
| 3 | Negative | 4 (80.0) | 1 (16.7) | <.05 |
|
| ||||
| Positive | 1 (20.0) | 5 (83.3) | ||
|
| ||||
| 12-month follow-up | ||||
|
| ||||
| Total | Negative | 61 (95.3) | 44 (72.1) | <.0001 |
|
| ||||
| Positive | 3 (4.7) | 17 (27.9) | ||
|
| ||||
| Age (years) | ||||
|
| ||||
| ≤ 25 | Negative | 9 (100.0) | 5 (71.4) | NS |
|
| ||||
| Positive | 0 (0) | 2 (28.6) | ||
|
| ||||
| > 25 | Negative | 52 (94.5) | 39 (72.2) | <.005 |
|
| ||||
| Positive | 3 (5.5) | 15 (27.8) | ||
|
| ||||
| Gender | ||||
|
| ||||
| Females | Negative | 45 (93.8) | 32 (76.2) | <.05 |
|
| ||||
| Positive | 3 (6.2) | 10 (23.8) | <.05 | |
|
| ||||
| Males | Negative | 16 (100) | 12 (63.2) | |
|
| ||||
| Positive | 0 (0) | 7 (36.8) | ||
|
| ||||
| Grade 2 | ||||
|
| ||||
| 1 | Negative | 37 (100) | 29 (87.9) | <.05 |
|
| ||||
| Positive | 0 (0) | 4 (12.1) | ||
|
| ||||
| 2 | Negative | 19 (86.4) | 14 (63.6) | NS |
|
| ||||
| Positive | 3 (13.6) | 8 (36.4) | ||
|
| ||||
| 3 | Negative | 5 (100) | 1 (16.7) | <.05 |
|
| ||||
| Positive | 0 (0) | 5 (83.3) | ||
1X2 test.
2Patients were classified into 3 lesion degrees, according to the number of genital areas affected by condylomas and the number of the condylomas: (1) from 1 to 5 condylomas on 1-2 genital areas (mild and localized condylomatosis); (2) > 5 condylomas on 2-3 genital areas (mild and diffuse condylomatosis); and (3) > 5 condylomas on > 3 genital areas (extended condylomatosis).